A share price of Mimedx Group Inc [MDXG] is currently trading at $8.10, down -0.25%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The MDXG shares have gain 0.19% over the last week, with a monthly amount drifted -2.99%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Mimedx Group Inc [NASDAQ: MDXG] stock has seen the most recent analyst activity on July 02, 2024, when Cantor Fitzgerald initiated its Overweight rating and assigned the stock a price target of $11. Previously, Lake Street started tracking the stock with Buy rating on March 07, 2024, and set its price target to $12. On October 27, 2023, Craig Hallum initiated with a Buy rating and assigned a price target of $12 on the stock. Mizuho started tracking the stock assigning a Buy rating and suggested a price target of $7 on October 13, 2022. Northland Capital initiated its recommendation with a Outperform and recommended $23 as its price target on July 26, 2021. H.C. Wainwright started tracking with a Buy rating for this stock on March 19, 2021, and assigned it a price target of $20.
Mimedx Group Inc experienced fluctuations in its stock price throughout the past year between $5.47 and $10.14. Currently, Wall Street analysts expect the stock to reach $16 within the next 12 months. Mimedx Group Inc [NASDAQ: MDXG] shares were valued at $8.10 at the most recent close of the market. An investor can expect a potential return of 97.53% based on the average MDXG price forecast.
Analyzing the MDXG fundamentals
Trailing Twelve Months sales for Mimedx Group Inc [NASDAQ:MDXG] were 348.88M which represents 7.00% growth. Gross Profit Margin for this corporation currently stands at 0.83% with Operating Profit Margin at 0.17%, Pretax Profit Margin comes in at 0.16%, and Net Profit Margin reading is 0.12%. To continue investigating profitability, this company’s Return on Assets is posted at 0.16, Equity is 0.24 and Total Capital is 0.27. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.01.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 7.92 points at the first support level, and at 7.74 for the second support level. However, for the 1st resistance point, the stock is sitting at 8.24, and for the 2nd resistance point, it is at 8.38.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Mimedx Group Inc [NASDAQ:MDXG] is 4.21. In addition, the Quick Ratio stands at 3.69 and the Cash Ratio stands at 2.29. Considering the valuation of this stock, the price to sales ratio is 3.42, the price to book ratio is 6.16 and price to earnings (TTM) ratio is 28.47.
Transactions by insiders
Recent insider trading involved Hulse William Frank IV, General Counsel and CAO, that happened on Mar 10 ’25 when 81446.0 shares were sold. Officer, Hulse William Frank IV completed a deal on Mar 10 ’25 to buy 81446.0 shares. Meanwhile, Chief Commercial Officer Maersk-Moller Kimberly sold 2111.0 shares on Feb 28 ’25.
